|   News

Atlas Venture’s 2018 Year in Review


2018 was an active and exciting year in the Atlas portfolio. Six of our portfolio companies went public, the drug developed by Arteaus was approved, we announced our first Opportunity Fund, and so much more. Check out our newsletter for the highlights.

Read more.